Remission of severe autoimmune bullous disorders induced by long-term extracorporeal photochemotherapy

Transfusion and Apheresis Science

Volumn 43, Issue 3, 2010, Pages 353-359

  Sanli, Hatice ^a   Akay, Bengu Nisa ^a   Ayyildiz, Erol ^b   Anadolu, Rana ^a   Ilhan, Osman ^b  

^a ANKARA UNIVERSITY   (Turkey)

^b Hemapharesis Unit and Blood Bank   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; COLCHICINE; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; DAPSONE; IMMUNOGLOBULIN; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISOLONE; RITUXIMAB;

ADJUVANT THERAPY; ADRENAL INSUFFICIENCY; ADULT; ANTIBODY TITER; ARTICLE; AVASCULAR NECROSIS; BONE MARROW SUPPRESSION; CATARACT; CLINICAL ARTICLE; DISEASE DURATION; DRUG EFFICACY; DRUG MEGADOSE; DRUG TOLERABILITY; EPIDERMOLYSIS BULLOSA ACQUISITA; FEMALE; FEMUR HEAD NECROSIS; HUMAN; LIVER TOXICITY; LOW DRUG DOSE; MALE; OSTEOPOROSIS; PEMPHIGUS VULGARIS; PHOTOCHEMOTHERAPY; REMISSION; TREATMENT OUTCOME; TREATMENT RESPONSE;

ADULT; AUTOIMMUNE DISEASES; DRUG RESISTANCE; EPIDERMOLYSIS BULLOSA ACQUISITA; FEMALE; HUMANS; MALE; MIDDLE AGED; PEMPHIGUS; PHOTOPHERESIS; PREDNISOLONE; REMISSION INDUCTION; RETROSPECTIVE STUDIES;

EID: 78649488159     PISSN: 14730502     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transci.2010.10.006     Document Type: Article

References (40)

1. Buchman A.L. Side effects of corticosteroid therapy. J Clin Gastroenterol 2001, 33:289-294.
2. Dick S.E., Werth V.P. Pemphigus: a treatment update. Auoimmunity 2006, 39:591-599.
3. Yeh S.W., Sami N., Ahmed A.R. Tretament of pemphigus vulgaris: 10 current and emerging options. Am J Clin Dermatol 2005, 6:327-342.
4. Prajapati V., Mydlarski P.R. Advances in pemphigus therapy. Skin Therapy Lett 2008, 13:4-7.
5. Woodley D.T., Sarret Y., Briggaman R.A. Autoimmunity to type VII collagen. Semin Dermatol 1991, 10:232-239.
6. Woodley D.T., Briggaman R.A., Gammon W.R. Acquired epidermolysis bullosa: a bullous disease associated with autoimmunity to type VII (anchoring fibril) collagen. Dermatol Clin 1990, 8:717-726.
7. Engineer L., Ahmed A.R. Emerging therapies for epidermolysis bullosa acquisita. J Am Acad Dermatol 2001, 44:818-828.
8. Rook A.H., Jegasothy B.V., Heald P., Nahass G.T., Ditre C., Witmer W.K., et al. Extracorporeal photochemotherapy for drug-resistant pemphigus vulgaris. Ann Intern Med 1990, 112:303-305.
9. Liang G., Nahass G., Kerdel F.A. Pemphigus vulgaris treated with photopheresis. J Am Acad Dermatol 1992, 26:779-780.
10. Gollnick H.P., Owsianowski M., Taube K.M., Orfanos C.E. Unresponsive severe generalized pemphigus vulgaris successfully controlled by extracorporeal photopheresis. J Am Acad Dermatol 1993, 28:122-124.
11. Azana J.M., de Misa R.F., Harto A., Ledo A. Severe pemphigus foliaceus treated with extracorporeal photochemotherapy. Arch Dermatol 1997, 133:287-289.
12. Wollina U., Lange D., Looks A. Short-time extracorporeal photochemotherapy in the treatment of drug-resistant autoimmune bullous diseases. Dermatology 1999, 198:140-144.
13. Owsianowski M., Garbe C., Ramaker J., Orfanos C.E., Gollnick H. Therapeutic experiences with extracorporeal photopheresis. Technical procedure, follow-up and clinical outcome in 31 skin diseases. Hautarzt 1996, 47:114-123.
14. Miller J.L., Stricklin G.P., Fine J.D., King L.E., Arzubiaga M.C., Ellis D.L. Remission of severe epidermolysis bullosa acquisita induced by extracorporeal photochemotherapy. Br J Dermatol 1995, 133:467-471.
15. Gordon K.B., Chan L.S., Woodley D.T. Treatment of refractory epidermolysis bullosa acquisita with extracorporeal photochemotherapy. Br J Dermatol 1997, 136:415-420.
16. Camara A., Bécherel P.A., Bussel A., Lagrange S., Chosidow O., Joly P., et al. Resistant acquired bullous epidermolysis with severe ocular involvement: the success of extracorporeal photochemotherapy. Ann Dermatol Venereol 1999, 126:612-615.
17. Edelson R., Berger C., Gasparro F., Jegasothy B., Heald P., Wintroub B., et al. Treatment of cutaneous-T cell lymphoma by extracorporeal photochemotherapy. Preliminary results. N Engl J Med 1987, 316:297-303.
18. Knobler R.M., Graninger W., Lindmaier A., Trautinger F., Smolen J. Extracorporeal photochemotherapy for the treatment of systemic lupus erythematosus. Arthritis Rhem 1992, 35:319-324.
19. Rook A.H., Heald P.W., Nahass G.T., Macey W., Witmer W.K., Lazarus G.S., et al. Treatment of autoimmune disease with extracorporeal photochemotherapy: pemphigus vulgaris-preliminary report. Yale J Biol Med 1989, 62:647-652.
20. McKenna K.E., Whittaker S., Rhodes L.E., Taylor P., Lloyd J., Ibbotson S., et al. Evidence-based practice of photopheresis 1987-2001: a report of a workshop of the British Photodermatology Group and the U.K. Skin Lymphoma Group. Br J Dermatol 2006, 154:7-20.
21. Knobler R., Barr M.L., Couriel D.R., Ferrara J.L., French L.E., Jaksch P., et al. Extracorporeal photopheresis: past, present and future. J Am Acad Dermatol 2009, 61:652-665.
22. Perez M., Edelson R.L., Laroche L., Berger C. Specific suppression of antiallograft immunity by immunization with syngeneic photoinactivatd effector lymphocytes. J Invest Dermatol 1989, 92:669-676.
23. Maeda A., Schwarz A., Kernebeck K., Gross N., Aragane Y., Peritt D., et al. Intravenous infusion of syngeneic apoptotic cells by photopheresis induces antigen-specific regulatory T cells. J Immunol 2005, 174:5968-5976.
24. Roncarolo M.G., Bacchetta R., Bordignon C., Narula S., Levings M.K. Type 1 T regulatory cells. Immunol Rev 2001, 182:68-79.
25. Chatenoud L., Salomon B., Bluestone J.A. Suppressor T cells - they're back and critical for regulation of autoimmunity. Immunol Rev 2001, 182:149-163.
26. + regulatory T cells generated ex vivo with IL-2 and TGF-beta suppress a stimulatory graft-versus-host disease with a lupus-like syndrome. J Immunol 2004, 172:1531-1539.
27. Wood K.J., Sakaguchi S. Regulatory T cells in transplantation tolerance. Nat Rev Immunol 2003, 3:199-210.
28. Lamioni A., Parisi F., Isacchi G., Giorda E., Di Cesare S., Landolfo A., et al. The immunological effects of extracorporeal photopheresis unraveled: induction of tolerogenic dendritic cells in vitro and regulatory T cells in vivo. Transplantation 2005, 79:846-850.
29. Albert M.L. Death-defying immunity: do apoptotic cells influence antigen processing and presentation?. Nat Rev Immunol 2004, 4:223-231.
30. Savill J., Dransfield I., Gregory C., Haslett C. A blast from the past: clearance of apoptotic cells regulates immune responses. Nat Rev Immunol 2002, 2:965-975.
31. Gerner M., Hölig K., Wehner R., Zhao S., Schäkel K., Bachmann M.P., et al. Extracorporeal photopheresis efficiently impairs the proinflammatory capacity of human 6-sulfo LacNAc dendritic cells. Transplantation 2009, 87:1134-1139.
32. Sakaguchi S., Sakaguchi N., Asano M., Itoh M., Toda M. Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J Immunol 1995, 55:1151-1164.
33. Brunkow M.E., Jeffery E.W., Hjerrild K.A., Paeper B., Clark L.B., Yasayko S.A., et al. Disruption of a new forkhead/winged-helix protein, scurfin, results in the fatal lymphoproliferative disorder of the scurfy mouse. Nat Genet 2001, 27:68-73.
34. Wildin R.S., Ramsdell F., Peake J., Faravelli F., Casanova J.L., Buist N., et al. X-linked neonatal diabetes mellitus, enteropathy and endocrinopathy syndrome is the human equivalent of mouse scurfy. Nat Genet 2001, 27:18-20.
35. + regulatory T cells. Nat Immunol 2003, 4:304-306.
36. Waterhouse P., Penninger J.M., Timms E., Wakeham A., Shahinian A., Lee K.P., et al. Lymphoproliferative disorders with early lethality in mice deficient in Ctla-4. Science 1995, 70:985-988.
37. Veldman C., Höhne A., Dieckmann D., Schuler G., Hertl M. Type I regulatory T cells specific for desmoglein 3 are more frequently detected in healthy individuals than in patients with pemphigus vulgaris. J Immunol 2004, 172:6468-6475.
38. Veldman C., Pahl A., Beissert S., Hansen W., Buer J., Dieckmann D., et al. Inhibition of the transcription factor Foxp3 converts desmoglein 3-specific type 1 regulatory T cells into Th2-like cells. J Immunol 2006, 176:3215-3222.
39. Gatza E., Rogers C.E., Clouthier S.G., Lowler K.P., Tawara I., Liu C., et al. Extracorporeal photopheresis reverses experimental graft-versus-host disease through regulatory T cells. Blood 2008, 112:1515-1521.
40. + functional regulatory T-cells in patients with graft-versus-host disease. Transplantation 2007, 84:31-39.